Advertisement
Screener

BioVie Inc. (BIVI) Form CORRESP: Company correspondence with SEC staff

BioVie Inc. Form CORRESP: Company correspondence with SEC staff

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2025-08-04: Form CORRESP; Description Company correspondence with SEC staff; Document filename1.htm.
  • 2025-08-04: Form CORRESP; Description Company correspondence with SEC staff; Document filename1.htm.
  • 2025-07-24: Form CORRESP; Description Company correspondence with SEC staff; Document filename1.htm.
  • 2025-07-24: Form CORRESP; Description Company correspondence with SEC staff; Document filename1.htm.
FiledFormPeriod of reportDescriptionDocument
2025-08-04CORRESPCompany correspondence with SEC stafffilename1.htm
2025-08-04CORRESPCompany correspondence with SEC stafffilename1.htm
2025-07-24CORRESPCompany correspondence with SEC stafffilename1.htm
2025-07-24CORRESPCompany correspondence with SEC stafffilename1.htm
2025-07-22CORRESPCompany correspondence with SEC stafffilename1.htm
2025-07-22CORRESPCompany correspondence with SEC stafffilename1.htm
2024-11-29CORRESPCompany correspondence with SEC stafffilename1.htm
2024-03-15CORRESPCompany correspondence with SEC stafffilename1.htm
2023-08-24CORRESPCompany correspondence with SEC stafffilename1.htm
2023-04-07CORRESPCompany correspondence with SEC stafffilename1.htm
2023-04-06CORRESPCompany correspondence with SEC stafffilename1.htm
2021-02-01CORRESPCompany correspondence with SEC stafffilename1.htm
2020-09-16CORRESPCompany correspondence with SEC stafffilename1.htm
2020-09-16CORRESPCompany correspondence with SEC stafffilename1.htm
2019-11-07CORRESPCompany correspondence with SEC stafffilename1.htm
2019-11-07CORRESPCompany correspondence with SEC stafffilename1.htm
2019-11-05CORRESPCompany correspondence with SEC stafffilename1.htm
2019-11-05CORRESPCompany correspondence with SEC stafffilename1.htm
2019-10-04CORRESPCompany correspondence with SEC stafffilename1.htm
2019-08-12CORRESPCompany correspondence with SEC stafffilename1.htm
2019-08-08CORRESPCompany correspondence with SEC stafffilename1.htm
2019-08-08CORRESPCompany correspondence with SEC stafffilename1.htm
2019-07-09CORRESPCompany correspondence with SEC stafffilename1.htm
2019-06-28CORRESPCompany correspondence with SEC stafffilename1.htm
2017-03-28CORRESPCompany correspondence with SEC stafffilename1.htm
2016-06-07CORRESPCompany correspondence with SEC stafffilename1.htm
2016-05-19CORRESPCompany correspondence with SEC stafffilename1.htm
2013-11-07CORRESPCompany correspondence with SEC stafffilename1.htm

Similar stocks

Stock NameCountryMarket CapPE Ratio
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
ADIAL PHARMACEUTICALS, INC. (ADIL)United States$0.012B
Phio Pharmaceuticals Corp. (PHIO)United States$0.012B-0.92
Tempest Therapeutics, Inc. (TPST)United States$0.013B
Scienture Holdings, Inc. (SCNX)United States$0.012B-0.38
KIORA PHARMACEUTICALS INC (KPRX)United States$0.012B
Dare Bioscience, Inc. (DARE)United States$0.011B
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36
MUSTANG BIO, INC. (MBIO)United States$0.013B
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14